Karl-Erik Andersson
51 – 60 of 170
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
Pharmacological characterization of a novel investigational antimuscarinic drug, fesoterodine, in vitro and in vivo.
Ney, Peter ; Pandita, Raj Kumar ; Newgreen, Donald T ; Breidenbach, Alexander ; Stöhr, Thomas and Andersson, Karl-Erik LU
(2008)
In BJU International
101.
p.1036-1042
- Contribution to journal › Article
- 2007
-
Mark
Dysregulation of cGMP-dependent protein kinase 1 (PKG-1) impairs erectile function in diabetic rats: influence of in vivo gene therapy of PKG1 alpha
Bivalacqua, Trinity J. ; Kendirci, Muammer ; Champion, Hunter C. ; Hellstrom, Wayne J. G. ; Andersson, Karl-Erik LU
and Hedlund, Petter
LU
(2007)
In BJU International
99(6).
p.1488-1494
- Contribution to journal › Article
-
Mark
Merck fellowships contribute to the continued growth of clinical pharmacology in Sweden
Sjoqvist, Folke ; Eriksson, Lars-Olof and Andersson, Karl-Erik LU
(2007)
In European Journal of Clinical Pharmacology
63(3).
p.229-231
- Contribution to journal › Debate/Note/Editorial
-
Mark
Effect of melatonin on age associated changes in guinea pig bladder function
Gomez-Pinilla, Pedro J. ; Gomez, Maria LU
; Hedlund, Petter
LU
; Swärd, Karl
LU
; Hellstrand, Per
LU
; Camello, Pedro J.
; Pozo, Maria J.
and Andersson, Karl-Erik
LU
(2007)
In Journal of Urology
177(4).
p.1558-1561
- Contribution to journal › Article
-
Mark
Effects of Tolterodine on Afferent Neurotransmission in Normal and Resiniferatoxin Treated Conscious Rats.
Hedlund, Petter LU ; Streng, Tomi LU ; Lee, Tack LU and Andersson, Karl-Erik LU
(2007)
In Journal of Urology
178(1).
p.326-331
- Contribution to journal › Article
-
Mark
Phosphodiesterases (PDEs) and PDE inhibitors for treatment of LUTS
Andersson, Karl-Erik LU
; Uckert, Stefan
; Stief, Christian
and Hedlund, Petter
LU
(2007)
In Neurourology and Urodynamics
26(6).
p.928-933
- Contribution to journal › Article
-
Mark
Urodynamic effects of a novel EP(1) receptor antagonist in normal rats and rats with bladder outlet obstruction.
Lee, Tack LU ; Hedlund, Petter LU ; Newgreen, Donald and Andersson, Karl-Erik LU
(2007)
In Journal of Urology
177(4).
p.1562-1567
- Contribution to journal › Article
-
Mark
Immunohistochemical Distribution of Cyclic GMP-Dependent Protein Kinase-1 in Human Prostate Tissue.
Waldkirch, Eginhard S ; Uckert, Stefan ; Langnase, Kristina ; Richter, Karin ; Jonas, Udo ; Wolf, Gerald ; Andersson, Karl-Erik LU
; Stief, Christian G
and Hedlund, Petter
LU
(2007)
In European Urology
52(2).
p.495-502
- Contribution to journal › Article
- 2006
-
Mark
Antimuscarinic drugs in detrusor overactivity and the overactive bladder syndrome: motor or sensory actions?
Finney, Steven M. ; Andersson, Karl-Erik LU
; Gillespie, James I.
and Stewart, Laurence H.
(2006)
In BJU International
98(3).
p.503-507
- Contribution to journal › Article
-
Mark
Oral treatment with a vitamin D3 analogue (BXL628) has anti-inflammatory effects in rodent model of interstitial cystitis
Benigni, F ; Baroni, E ; Zecevic, M ; Zvara, P ; Streng, Tomi LU ; Hedlund, Petter LU ; Colli, E ; D'Ambrosio, D and Andersson, Karl-Erik LU
(2006)
In BJU International
97(3).
p.617-624
- Contribution to journal › Article